Successful psychopharmacotherapy of anxiety and depressive disorders improve functional limitations in patients with rheumatoid arthritis

Aim. To compare changes in functional limitations in patients with rheumatoid arthritis (RA) and comorbid anxiety and depressive disorders (ADD) treated with conventional synthetic disease-modifying antirheumatic drugs (csDMARDs) alone or in combination with biologic DMARDs (bDMARDs) and/or psychoph...

Full description

Bibliographic Details
Main Authors: Anton A. Abramkin, Tatiana A. Lisitsyna, Dmitry Yu. Veltishchev, Olga F. Seravina, Oksana B. Kovalevskaya, Svetlana I. Glukhova, Evgeny L. Nasonov
Format: Article
Language:Russian
Published: "Consilium Medicum" Publishing house 2022-06-01
Series:Терапевтический архив
Subjects:
Online Access:https://ter-arkhiv.ru/0040-3660/article/viewFile/108777/82888